MXPA05009763A - 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto. - Google Patents
2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto.Info
- Publication number
- MXPA05009763A MXPA05009763A MXPA05009763A MXPA05009763A MXPA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A MX PA05009763 A MXPA05009763 A MX PA05009763A
- Authority
- MX
- Mexico
- Prior art keywords
- benzamid
- sulfonylamino
- pyridin
- methoxy
- propyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 206010003658 Atrial Fibrillation Diseases 0.000 abstract 2
- 206010003662 Atrial flutter Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
| PCT/EP2004/002247 WO2004083157A1 (de) | 2003-03-18 | 2004-03-05 | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05009763A true MXPA05009763A (es) | 2006-01-27 |
Family
ID=32920928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05009763A MXPA05009763A (es) | 2003-03-18 | 2004-03-05 | 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1606237A1 (https=) |
| JP (1) | JP2006520343A (https=) |
| KR (1) | KR20050110681A (https=) |
| CN (1) | CN100361943C (https=) |
| AR (1) | AR043622A1 (https=) |
| AU (1) | AU2004222137A1 (https=) |
| BR (1) | BRPI0408441A (https=) |
| CA (1) | CA2519022A1 (https=) |
| DE (1) | DE10312073A1 (https=) |
| HR (1) | HRP20050815A2 (https=) |
| MA (1) | MA27749A1 (https=) |
| MX (1) | MXPA05009763A (https=) |
| MY (1) | MY176510A (https=) |
| NO (1) | NO20054472L (https=) |
| NZ (1) | NZ542476A (https=) |
| PE (1) | PE20050307A1 (https=) |
| RS (1) | RS20050690A (https=) |
| RU (1) | RU2333202C2 (https=) |
| TW (1) | TW200500342A (https=) |
| WO (1) | WO2004083157A1 (https=) |
| ZA (1) | ZA200506328B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| WO2007015775A2 (en) * | 2005-07-22 | 2007-02-08 | Merck & Co., Inc. | Potassium channel inhibitors |
| EP2435407B1 (en) * | 2009-05-29 | 2019-12-25 | RaQualia Pharma Inc. | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0472053B1 (en) * | 1990-08-20 | 1998-06-17 | Eisai Co., Ltd. | Sulfonamide derivatives |
| DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Ceased
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de not_active Ceased
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20050307A1 (es) | 2005-06-08 |
| DE10312073A1 (de) | 2004-09-30 |
| TW200500342A (en) | 2005-01-01 |
| HK1086819A1 (en) | 2006-09-29 |
| RU2005132163A (ru) | 2006-04-10 |
| RS20050690A (sr) | 2008-04-04 |
| MY176510A (en) | 2020-08-12 |
| WO2004083157A1 (de) | 2004-09-30 |
| RU2333202C2 (ru) | 2008-09-10 |
| ZA200506328B (en) | 2006-04-26 |
| MA27749A1 (fr) | 2006-02-01 |
| CN100361943C (zh) | 2008-01-16 |
| BRPI0408441A (pt) | 2006-04-04 |
| JP2006520343A (ja) | 2006-09-07 |
| NZ542476A (en) | 2008-05-30 |
| CN1756728A (zh) | 2006-04-05 |
| AU2004222137A1 (en) | 2004-09-30 |
| KR20050110681A (ko) | 2005-11-23 |
| AR043622A1 (es) | 2005-08-03 |
| NO20054472L (no) | 2005-09-27 |
| CA2519022A1 (en) | 2004-09-30 |
| HRP20050815A2 (en) | 2006-09-30 |
| EP1606237A1 (de) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN03084A1 (en) | Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof | |
| TWI256950B (en) | Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| WO2001066564A3 (en) | Gamma-secretase inhibitors | |
| YU42503A (sh) | Arilovani furan-1 tiofen-amidi-karbonske kiseline sa blokirajućim dejstvom kalijumovog kanala | |
| WO2001064642A3 (en) | Benzamides and related inhibitors of factor xa | |
| BR0313176A (pt) | Composições de pirazol úteis como inibidores de gsk-3 | |
| WO2002085909A8 (en) | 9-deazaguanine derivatives as inhibitors of gsk-3 | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| TR200200883T2 (tr) | 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları | |
| MY128659A (en) | Novel aminodicarboxylic acid derivatives having pharmaceutical properties | |
| AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| GB0222514D0 (en) | Organic compounds | |
| NO20021367D0 (no) | Indolyl-3-glyoksylsyrederivater som har terapeutisk verdifulle egenskaper | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| SE9802208D0 (sv) | Novel compounds | |
| PT992509E (pt) | Novos derivados macrolidos | |
| IL152337A0 (en) | A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds | |
| HK1053833A1 (zh) | 取代苯基法呢基转移酶抑制剂 | |
| IL188092A0 (en) | Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them | |
| MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
| DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
| MXPA05009763A (es) | 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status | ||
| FG | Grant or registration |